187 related articles for article (PubMed ID: 19711746)
1. [Trazodone: a new selective approach to the treatment of hot flashes induced by androgen deprivation in prostate carcinoma?].
González SV; Puig FM; Martí SS; Sánchez MV; Capellán Mdel M; Martos MA
Actas Urol Esp; 2009 Jun; 33(6):635-8. PubMed ID: 19711746
[TBL] [Abstract][Full Text] [Related]
2. Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer.
Naoe M; Ogawa Y; Shichijo T; Fuji K; Fukagai T; Yoshida H
Prostate Cancer Prostatic Dis; 2006; 9(3):275-8. PubMed ID: 16786037
[TBL] [Abstract][Full Text] [Related]
3. Pilot evaluation of paroxetine for treating hot flashes in men.
Loprinzi CL; Barton DL; Carpenter LA; Sloan JA; Novotny PJ; Gettman MT; Christensen BJ
Mayo Clin Proc; 2004 Oct; 79(10):1247-51. PubMed ID: 15473404
[TBL] [Abstract][Full Text] [Related]
4. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
[TBL] [Abstract][Full Text] [Related]
5. Intravenous nutrient therapy eliminated androgen deprivation therapy-induced hot flashes in two men with prostate cancer.
Massey P
J Soc Integr Oncol; 2006; 4(4):153-6. PubMed ID: 17022923
[TBL] [Abstract][Full Text] [Related]
6. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture for hot flashes in men treated with androgen deprivation therapy.
Hirsch LM; Goldstein LE
Can J Urol; 2015 Aug; 22(4):7938-41. PubMed ID: 26267037
[TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation therapy-associated vasomotor symptoms.
Jones JM; Kohli M; Loprinzi CL
Asian J Androl; 2012 Mar; 14(2):193-7. PubMed ID: 22286861
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy.
Hanisch LJ; Gehrman PR
Aging Male; 2011 Dec; 14(4):243-8. PubMed ID: 21627561
[TBL] [Abstract][Full Text] [Related]
11. Managing hot flashes in men being treated for prostate cancer.
Baum NH; Torti DC
Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
[TBL] [Abstract][Full Text] [Related]
12. Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
Gonzalez BD; Jim HS; Donovan KA; Small BJ; Sutton SK; Park J; Lin HY; Spiess PE; Fishman MN; Jacobsen PB
J Urol; 2015 Sep; 194(3):690-5. PubMed ID: 25791402
[TBL] [Abstract][Full Text] [Related]
13. Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.
Smith TJ; Loprinzi CL; Deville C
N Engl J Med; 2018 May; 378(18):1745-1746. PubMed ID: 29719180
[No Abstract] [Full Text] [Related]
14. Complications of androgen-deprivation therapy for prostate cancer.
Holzbeierlein JM; Castle EP; Thrasher JB
Clin Prostate Cancer; 2003 Dec; 2(3):147-52. PubMed ID: 15040857
[TBL] [Abstract][Full Text] [Related]
15. Management of Androgen Deprivation Therapy-Associated Hot Flashes in Men With Prostate Cancer.
Qan'ir Y; DeDeaux D; Godley PA; Mayer DK; Song L
Oncol Nurs Forum; 2019 Jul; 46(4):E107-E118. PubMed ID: 31225840
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
17. [Management of the side effects of androgenic deprivation].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin for hot flashes in prostate cancer.
Jeffery SM; Pepe JJ; Popovich LM; Vitagliano G
Ann Pharmacother; 2002 Mar; 36(3):433-6. PubMed ID: 11895055
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
20. [Selective serotonin reuptake inhibitors (SSRIs) antidepressants use in hot flashes in oncology].
Elek T; Reich M
Rev Med Interne; 2004 Mar; 25(3):217-24. PubMed ID: 15049283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
